GlassScriptPhysician profile
Carly Schrage
NPI 1063778363
$1,555.10
in general payments reported to CMS, 2019-2025
10 companies · $51.51 in 2025
The $51.51 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $65.81 · 2021: $110 · 2022: $213 · 2023: $205 · 2024: $318 · 2025: $51.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,104.53 | 2019-2025 | Inspire |
| Intersect Ent, INC. | $224.11 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $56.51 | 2021 | |
| Biofrontera INC. | $54.61 | 2023-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Genzyme Corporation | $25.86 | 2024 | |
| Glaxosmithkline, LLC. | $25.29 | 2021 | |
| Optinose US, INC. | $18.79 | 2019 | |
| Medtronic USA, INC. | $16.00 | 2019 | |
| Aerin Medical INC. | $15.90 | 2024 | |
| Alk-Abello, INC | $13.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carly Schrage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.